Ash Meeting December 2024. This roundup of news from the ash 2024 conference first appeared in stat’s “ash in 30” newsletter. New approaches to predicting patient outcomes in hematologic malignancies.

Novo nordisk announced the presentation of 13 abstracts, three of which will be presented in oral sessions, at the upcoming 66 th annual meeting and exposition of the. Aptose clinical data featured in poster presentation at the 2024 ash annual meeting support tuspetinib triple drug therapy for newly diagnosed aml.